Uncovering the genetics of cirrhosis: New plots for the usual suspects

Common conditions associated with hereditary haemochromatosis genetic variants: cohort study in UK Biobank

(2019) Luke C Pilling et al.   BMJ-British Medical Journal

Liver Fibrosis and Metabolic Alterations in Adults with Alpha1 Antitrypsin Deficiency Caused by the Pi*ZZ Mutation

(2019) Karim Hamesch et al.   GASTROENTEROLOGY

Genetic studies of abdominal MRI data identify genes regulating hepcidin as major determinants of liver iron concentration

(2019) Henry R. Wilman et al.   JOURNAL OF HEPATOLOGY

Genetics and epigenetics of NAFLD and NASH: Clinical impact

(2018) Mohammed Eslam et al.   JOURNAL OF HEPATOLOGY

A Protein-Truncating HSD17B13 Variant and Protection from Chronic Liver Disease

(2018) Noura S. Abul-Husn et al.   NEW ENGLAND JOURNAL OF MEDICINE

Heterozygous carriage of the alpha1-antitrypsin Pi*Z variant increases the risk to develop liver cirrhosis

(2018) Pavel Strnad et al.   GUT

Hepatic fat as clinical outcome and therapeutic target for nonalcoholic fatty liver disease

(2018) Serena Pelusi et al.   LIVER INTERNATIONAL

Parental non-alcoholic fatty liver disease increases risk of non-alcoholic fatty liver disease in offspring

(2018) Michelle T. Long et al.   LIVER INTERNATIONAL

Causal relationship of hepatic fat with liver damage and insulin resistance in nonalcoholic fatty liver

(2017) P. Dongiovanni et al.   JOURNAL OF INTERNAL MEDICINE

Hepatic iron is the major determinant of serum ferritin in NAFLD patients

(2017) John D. Ryan et al.   LIVER INTERNATIONAL

The evolutionary adaptation of the C282Y mutation to culture and climate during the European Neolithic

(2016) Kathleen M. Heath et al.   AMERICAN JOURNAL OF PHYSICAL ANTHROPOLOGY

Hepcidin resistance in dysmetabolic iron overload

(2016) Raffaela Rametta et al.   LIVER INTERNATIONAL

Impaired hepcidin expression in alpha-1-antitrypsin deficiency associated with iron overload and progressive liver disease

(2015) Benedikt Schaefer et al.   HUMAN MOLECULAR GENETICS

A randomized trial of iron depletion in patients with nonalcoholic fatty liver disease and hyperferritinemia

(2014) Luca Valenti   WORLD JOURNAL OF GASTROENTEROLOGY

Iron in fatty liver and in the metabolic syndrome: A promising therapeutic target

(2011) Paola Dongiovanni et al.   JOURNAL OF HEPATOLOGY

HFE Genotype, Parenchymal Iron Accumulation, and Liver Fibrosis in Patients With Nonalcoholic Fatty Liver Disease

(2009) Luca Valenti et al.   GASTROENTEROLOGY